20. Ebola Virus Biology
Thursday, October 8, 2015: 8:30 AM-10:00 AM
Room: 28--ABCDE
Co-organized with the National Institute of Allergy and Infectious Diseases

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe state-of-the-art understanding of Ebola virus pathogenesis
  • discuss experimental therapeutics for Ebola virus disease treatment of post-exposure prophylaxis
  • review immune responses to Ebola virus disease and the approach to the development of an Ebola virus vaccine

Target Audience: Scientists, Vaccinologists, Researchers, Public health practitioners, Pharmacists, Nurses, Microbiologists, Members-in-training, Lab personnel, Investigators, Infectious diseases physicians, Infectious diseases pediatricians, Infection preventionists, Hospital epidemiologists, Healthcare workers, Fellows, Epidemiologists, Clinicians, Academicians

Tracks: Trainee, Pediatric ID, Investigative ID, Global ID, Epidemiology and Infection Control, Adult ID

Moderators:  Costi D. Sifri, MD, FIDSA, University of Virginia Health System and Nancy J. Sullivan, PhD, National Institutes of Health

8:30 AM
Ebola Virology and Host/Virus Interaction
Erica Ollmann Saphire, PhD

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: No CPE credit is offered for this session

ACPE Number:


C. D. Sifri, None

N. J. Sullivan, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.